Aptus Pharma earnings call announcements

Every Aptus Pharma earnings call announcement on NSE and BSE, newest first, each with its own page.

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Oct 2026 17:31 IST BSE

Aptus Pharma Investor Presentation: Key Takeaways

H1 FY27 revenue ₹48.92 Cr, EBITDA ₹7.68 Cr (15.7% margin), PAT ₹5.07 Cr; revenue exceeds full FY26 (₹46.57 Cr). Trading-heavy model with rising receivables and negative operating cash flow.

Open call summary → Read the filing ↗